Healthcare

Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research & development of next-generation biologic drugs, announced that it received a $3 million milestone payment from Shire plc (LSE: SHP, NASDAQ:SHPG) related to Shire’s advancing the Phase 1/2a clinical study for the PSA-Recombinant SHP656 or Factor VIII...

The medical device space has drawn a lot of attention as late. It's become one of those sectors - just as with the more chemical oriented biotech/healthcare space - that is prone to real swings and roundabouts as data hits from the clinical trial process. These data hits serve...

Ariad Pharmaceuticals Inc (NASDAQ:ARIA) shares popped up 72.85% to $23.75 on Monday then pulled back 0.04% to $23.74 in after-hours trading. Share prices have been trading in a 52-week range of $4.37 to $23.81 so it's already at the resistance. The company has a market cap of $4.73 billion...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Computer Programs & Systems Inc. (NASDAQ:CPSI) reported that Stadium Capital Management has picked up 1,379,151 of common stock as of 2017-01-06. The acquisition brings the aggregate amount owned by Stadium Capital Management to a total...

Conestoga has been busy in the New Year, with investments across the biotechnology sector, all reported today. Here at Small Cap Exclusive, of course, we're keeping up with things, however busy they may be. Here's what the latest filing has revealed. In a just published Form 13, filed with the...